178 related articles for article (PubMed ID: 33324976)
1. Drug Positivity Findings from a Universal Umbilical Cord Tissue Drug Analysis Program in Appalachia.
Yossuck P; Tacker DH
J Appl Lab Med; 2021 Jan; 6(1):285-297. PubMed ID: 33324976
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Neonatal Co-Exposure to Gabapentin and Commonly Abused Drugs Observed in Umbilical Cord Tissue.
Okoye NC; McMillin GA
J Anal Toxicol; 2021 May; 45(5):506-512. PubMed ID: 32860706
[TBL] [Abstract][Full Text] [Related]
3. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.
Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M
Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432
[TBL] [Abstract][Full Text] [Related]
4. Screening for Opioid and Stimulant Exposure In Utero Through Targeted and Untargeted Metabolomics Analysis of Umbilical Cords.
Mamillapalli SS; Smith-Joyner A; Forbes L; McIntyre K; Poppenfuse S; Rushing B; Strom C; Danell AS; May L; Kuehn D; Kew K; Ravisankar S
Ther Drug Monit; 2020 Oct; 42(5):787-794. PubMed ID: 32142018
[TBL] [Abstract][Full Text] [Related]
5. Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters.
Pandya V; Wilker C; McMillin GA
J Anal Toxicol; 2023 Feb; 47(1):96-105. PubMed ID: 35707888
[TBL] [Abstract][Full Text] [Related]
6. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
[TBL] [Abstract][Full Text] [Related]
7. Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center.
Palmer KL; Wood KE; Krasowski MD
Clin Biochem; 2017 Apr; 50(6):255-261. PubMed ID: 27890824
[TBL] [Abstract][Full Text] [Related]
8. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal trends in meconium drug detection in 46 US states between the years 2015 and 2020.
Pandya V; Wilker C; Johnson-Davis KL
J Anal Toxicol; 2023 Jul; 47(6):495-503. PubMed ID: 37079848
[TBL] [Abstract][Full Text] [Related]
10. Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.
Pesce A; West C; Gonzales E; Rosenthal M; West R; Mikel C; Almazan P; Latyshev S; Horn P
Pain Physician; 2012; 15(5):E687-92. PubMed ID: 22996862
[TBL] [Abstract][Full Text] [Related]
11. Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah.
Smid MC; Allshouse AA; McMillin GA; Nunez K; Cavin T; Worden J; Buchi K; Muniyappa B; Varner MW; Cochran G; Metz TD
Obstet Gynecol; 2022 Aug; 140(2):153-162. PubMed ID: 35852263
[TBL] [Abstract][Full Text] [Related]
12. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
13. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection.
Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M
Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
Atluri S; Sudarshan G; Manchikanti L
Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
[TBL] [Abstract][Full Text] [Related]
15. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey.
Montgomery DP; Plate CA; Jones M; Jones J; Rios R; Lambert DK; Schumtz N; Wiedmeier SE; Burnett J; Ail S; Brandel D; Maichuck G; Durham CA; Henry E; Christensen RD
J Perinatol; 2008 Nov; 28(11):750-3. PubMed ID: 18596707
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of drug use in pregnant West Virginia patients.
Stitely ML; Calhoun B; Maxwell S; Nerhood R; Chaffin D
W V Med J; 2010; 106(4 Spec No):48-52. PubMed ID: 21932753
[TBL] [Abstract][Full Text] [Related]
17. Detection of in utero cannabis exposure by umbilical cord analysis.
Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
[TBL] [Abstract][Full Text] [Related]
18. Substance use in pregnancy.
Wong S; Ordean A; Kahan M; ; ; ; ;
J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
[TBL] [Abstract][Full Text] [Related]
19. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure.
Colby JM
Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850
[TBL] [Abstract][Full Text] [Related]
20. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy.
González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR
J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
